Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5507)
All Articles published online
|
Publishing Process of This Article
|
Feb 21, 2022 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ermongkonchai T, Khor R, Muralidharan V, Tebbutt N, Lim K, Kutaiba N, Ng SP. Stereotactic radiotherapy and the potential role of magnetic resonance-guided adaptive techniques for pancreatic cancer. World J Gastroenterol 2022; 28(7): 745-754 [PMID: 35317275 DOI: 10.3748/wjg.v28.i7.745] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i7/745.htm |
| Number | Citing Articles |
| 1 |
Dazhen Jiang, Jin Peng, Hui Liu, Xiaoyong Wang, Fuxiang Zhou. Online Adaptive Radiotherapy for an Elderly Patient With Locally Advanced Pancreatic Cancer. Cureus 2024; doi: 10.7759/cureus.71382
|
| 2 |
冰 韩. Advances in Radiotherapy and Chemotherapy for Pancreatic Cancer. Advances in Clinical Medicine 2024; 14(07): 414 doi: 10.12677/acm.2024.1472030
|
| 3 |
D. Doppenberg, M. G. Besselink, C. H. J. van Eijck, M. P. W. Intven, B. Groot Koerkamp, G. Kazemier, H. W. M. van Laarhoven, M. Meijerink, I. Q. Molenaar, J. J. M. E. Nuyttens, R. van Os, H. C. van Santvoort, G. van Tienhoven, H. M. Verkooijen, E. Versteijne, J. W. Wilmink, F. J. Lagerwaard, A. M. E. Bruynzeel. Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10419-4
|
| 4 |
Rachael M. Martin-Paulpeter, P. James Jensen, Luis A. Perles, Gabriel O. Sawakuchi, Prajnan Das, Eugene J. Koay, Albert C. Koong, Ethan B. Ludmir, Joshua S. Niedzielski, Sam Beddar. Daily Diagnostic Quality Computed Tomography-on-Rails (CTOR) Image Guidance for Abdominal Stereotactic Body Radiation Therapy (SBRT). Cancers 2024; 16(22): 3770 doi: 10.3390/cancers16223770
|
| 5 |
Dazhen Jiang, Peng Jin, Hui Xu, Dajiang Wang, Conghua Xie, Xiaoyong Wang, Fuxiang Zhou, Hui Liu. Online adaptive radiotherapy in stereotactic body radiotherapy for pancreatic cancer patients. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-72831-z
|
| 6 |
Sofia Dallavalle, Gabriele Campagnoli, Paola Pastena, Alessandro Martinino, Davide Schiliró, Francesco Giovinazzo. New Frontiers in Pancreatic Cancer Management: Current Treatment Options and the Emerging Role of Neoadjuvant Therapy. Medicina 2024; 60(7): 1070 doi: 10.3390/medicina60071070
|
| 7 |
Jun Yeong Song, Eui Kyu Chie, Seong-Hee Kang, Yeon-Jun Jeon, Yoon-Ah Ko, Dong-Yun Kim, Hyun-Cheol Kang. Dosimetric evaluation of magnetic resonance imaging-guided adaptive radiation therapy in pancreatic cancer by extent of re-contouring of organs-at-risk. Radiation Oncology Journal 2022; 40(4): 242 doi: 10.3857/roj.2022.00332
|
| 8 |
Esther M.M. Smeets, Marija Trajkovic-Arsic, Daan Geijs, Sinan Karakaya, Monica van Zanten, Lodewijk A.A. Brosens, Benedikt Feuerecker, Martin Gotthardt, Jens T. Siveke, Rickmer Braren, Francesco Ciompi, Erik H.J.G. Aarntzen. Histology-Based Radiomics for [18F]FDG PET Identifies Tissue Heterogeneity in Pancreatic Cancer. Journal of Nuclear Medicine 2024; 65(7): 1151 doi: 10.2967/jnumed.123.266262
|
| 9 |
Tony Young, Mark Lee, Meredith Johnston, Theresa Nguyen, Rebecca Ko, Sankar Arumugam. Assessment of interfraction dose variation in pancreas SBRT using daily simulation MR images. Physical and Engineering Sciences in Medicine 2023; 46(4): 1619 doi: 10.1007/s13246-023-01324-6
|
| 10 |
Hilario Yankey, Karen J. Ruth, Efrat Dotan, Sanjay Reddy, Joshua E. Meyer. Survival and Toxicity in Patients With Unresectable or Inoperable Biliary Tract Cancers With Ablative Radiation Therapy Versus Nonablative Chemoradiation. Advances in Radiation Oncology 2024; 9(4): 101412 doi: 10.1016/j.adro.2023.101412
|
| 11 |
Chao Jiang, Zhiwei Jiang, Shuxin Dai, Dengxiong Li, Ruicheng Wu, Jie Wang, Qingxin Yu, Luxia Ye, Fanglin Shao, Zhipeng Wang, Koo Han Yoo, Yubo Yang, Mang Ke, William C. Cho, Wuran Wei, Zhouting Tuo, Dechao Feng. The application of 3D printing technology in tumor radiotherapy in the era of precision medicine. Applied Materials Today 2024; 40: 102368 doi: 10.1016/j.apmt.2024.102368
|
| 12 |
Giulia Pacella, Maria Chiara Brunese, Eleonora D’Imperio, Marco Rotondo, Andrea Scacchi, Mattia Carbone, Germano Guerra. Pancreatic Ductal Adenocarcinoma: Update of CT-Based Radiomics Applications in the Pre-Surgical Prediction of the Risk of Post-Operative Fistula, Resectability Status and Prognosis. Journal of Clinical Medicine 2023; 12(23): 7380 doi: 10.3390/jcm12237380
|
| 13 |
Xiaotao Dong, Kunlun Wang, Hui Yang, Ruilan Cheng, Yan Li, Yanqi Hou, Jiali Chang, Ling Yuan. The Nomogram predicting the overall survival of patients with pancreatic cancer treated with radiotherapy: a study based on the SEER database and a Chinese cohort. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1266318
|
| 14 |
Petr Burkoň, Jan Trna, Marek Slávik, Radim Němeček, Tomáš Kazda, Petr Pospíšil, Milan Dastych, Michal Eid, Ivo Novotný, Tomáš Procházka, Miroslav Vrzal. Stereotactic Body Radiotherapy (SBRT) of Pancreatic Cancer—A Critical Review and Practical Consideration. Biomedicines 2022; 10(10): 2480 doi: 10.3390/biomedicines10102480
|
| 15 |
Karl Bordeau, Morgan Michalet, Aïcha Keskes, Simon Valdenaire, Pierre Debuire, Marie Cantaloube, Morgane Cabaillé, Fabienne Portales, Roxana Draghici, Marc Ychou, Eric Assenat, Thibault Mazard, Emmanuelle Samalin, Ludovic Gauthier, Pierre-Emmanuel Colombo, Sebastien Carrere, François-Régis Souche, Norbert Aillères, Pascal Fenoglietto, David Azria, Olivier Riou. Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study. Cancers 2022; 15(1): 7 doi: 10.3390/cancers15010007
|
| 16 |
Hrvoje Kaučić, Domagoj Kosmina, Dragan Schwarz, Andreas Mack, Hrvoje Šobat, Adlan Čehobašić, Vanda Leipold, Iva Andrašek, Asmir Avdičević, Mihaela Mlinarić. Stereotactic Ablative Radiotherapy Using CALYPSO® Extracranial Tracking for Intrafractional Tumor Motion Management—A New Potential Local Treatment for Unresectable Locally Advanced Pancreatic Cancer? Results from a Retrospective Study. Cancers 2022; 14(11): 2688 doi: 10.3390/cancers14112688
|
| 17 |
Ran Ni, Zhiming Hu, Ran Tao. Advances of immune-checkpoint inhibition of CTLA-4 in pancreatic cancer. Biomedicine & Pharmacotherapy 2024; 179: 117430 doi: 10.1016/j.biopha.2024.117430
|
| 18 |
Florentine E F Timmer, Bart Geboers, Alette H Ruarus, Laurien G P H Vroomen, Evelien A C Schouten, Susan van der Lei, Danielle J W Vos, Madelon Dijkstra, Hannah H Schulz, Joyce Bakker, Bente A T van den Bemd, Petrousjka M van den Tol, Robbert S Puijk, Birgit I Lissenberg-Witte, Tanja D de Gruijl, Jan J J de Vries, Frank J Lagerwaard, Hester J Scheffer, Anna M E Bruynzeel, Martijn R Meijerink. MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial. The Lancet Gastroenterology & Hepatology 2024; 9(5): 448 doi: 10.1016/S2468-1253(24)00017-7
|